James Crowe
Faculty Member
Last active: 3/31/2019

  1. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies. Bornholdt ZA, Ndungo E, Fusco ML, Bale S, Flyak AI, Crowe JE, Chandran K, Saphire EO (2016) MBio 7(1): e02154-15
    › Primary publication · 26908579 (PubMed) · PMC4791852 (PubMed Central)
  2. H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, Li S, Wilson IA, García-Sastre A, Albrecht RA, Crowe JE (2016) J Clin Invest 126(4): 1482-94
    › Primary publication · 26950424 (PubMed) · PMC4811156 (PubMed Central)
  3. Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1. Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS (2016) J Virol 90(10): 5090-5097
    › Primary publication · 26962223 (PubMed) · PMC4859728 (PubMed Central)
  4. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding. Sapparapu G, Czakó R, Alvarado G, Shanker S, Prasad BV, Atmar RL, Estes MK, Crowe JE (2016) PLoS Pathog 12(6): e1005719
    › Primary publication · 27355511 (PubMed) · PMC4927092 (PubMed Central)
  5. Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1. Boehme KW, Ikizler M, Iskarpatyoti JA, Wetzel JD, Willis J, Crowe JE, LaBranche CC, Montefiori DC, Wilson GJ, Dermody TS (2016) mSphere 1(3)
    › Primary publication · 27303748 (PubMed) · PMC4888892 (PubMed Central)
  6. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation. Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE (2016) Haematologica 101(5): e204-8
    › Primary publication · 26819055 (PubMed) · PMC5004357 (PubMed Central)
  7. Development of Human Monoclonal Antibodies Against Respiratory Syncytial Virus Using a High Efficiency Human Hybridoma Technique. Alvarado G, Crowe JE (2016) Methods Mol Biol : 63-76
    › Primary publication · 27464688 (PubMed)
  8. Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6. Cho MJ, Ellebrecht CT, Hammers CM, Mukherjee EM, Sapparapu G, Boudreaux CE, McDonald SM, Crowe JE, Payne AS (2016) J Immunol 197(4): 1065-73
    › Primary publication · 27402694 (PubMed) · PMC4976025 (PubMed Central)
  9. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site. Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE (2016) J Virol 90(2): 780-9
    › Primary publication · 26512092 (PubMed) · PMC4702676 (PubMed Central)
  10. Deep sequencing and human antibody repertoire analysis. Boyd SD, Crowe JE (2016) Curr Opin Immunol : 103-9
    › Primary publication · 27065089 (PubMed) · PMC5203765 (PubMed Central)